Email this article Updates in urologic oncology guidelines: prostate cancer: A review
- Authors: Volkova M.I.1,2, Alekseev B.Y.3,4, Nosov D.A.5, Nyushko K.M.6
-
Affiliations:
- Russian Medical Academy of Continuous Professional Education
- City Clinical Oncology Hospital №1
- Russian Biotechnological University
- National Medical Research Center for Radiology
- Central Clinical Hospital with a Polyclinic
- Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre
- Issue: Vol 25, No 1 (2023)
- Pages: 15-20
- Section: CLINICAL ONCOLOGY
- URL: https://ogarev-online.ru/1815-1434/article/view/132789
- DOI: https://doi.org/10.26442/18151434.2023.1.202136
- ID: 132789
Cite item
Full Text
Abstract
The emergence of new drug therapy regimens and the completion of several large randomized trials led to significant changes in the clinical guidelines of the Ministry of Health of Russia and the practical guidelines of the Russian Society of Clinical Oncology (RUSSCO) for the treatment of urologic oncology diseases. However, different interpretations of some studies by expert panels and requirements for these documents led to a divergence of some statements in these publications. The article presents executive summaries of the updated clinical and practical prostate cancer treatment guidelines.
Full Text
##article.viewOnOriginalSite##About the authors
Maria I. Volkova
Russian Medical Academy of Continuous Professional Education; City Clinical Oncology Hospital №1
Author for correspondence.
Email: mivolkova6@gmail.com
D. Sci. (Med.), Russian Medical Academy of Continuous Professional Education, City Clinical Oncology Hospital №1
Russian Federation, Moscow; MoscowBoris Ya. Alekseev
Russian Biotechnological University; National Medical Research Center for Radiology
Email: mivolkova6@gmail.com
ORCID iD: 0000-0002-3398-4128
D. Sci. (Med.), Prof., Russian Biotechnological University, National Medical Research Center for Radiology
Russian Federation, Moscow; MoscowDmitry A. Nosov
Central Clinical Hospital with a Polyclinic
Email: mivolkova6@gmail.com
ORCID iD: 0000-0001-8415-5197
D. Sci. (Med.), Prof., Central Clinical Hospital with a Polyclinic
Russian Federation, MoscowKirill M. Nyushko
Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre
Email: mivolkova6@gmail.com
ORCID iD: 0000-0002-4171-6211
D. Sci. (Med.), Prof., Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre
Russian Federation, MoscowReferences
- Клинические рекомендации МЗ РФ. Рак предстательной железы. Режим доступа: https://old.oncology-association.ru/clinical-guidelines-update. Ссылка активна на 15.12.2022 [Clinical recommendations of the Ministry of Health of the Russian Federation. Prostate cancer. Available at: https://old.oncology-association.ru/clinical-guidelines-update. Accessed: 15.12.2022 (in Russian)].
- Носов Д.А., Волкова М.И., Гладков О.А., и др. Практические рекомендации по лечению рака предстательной железы. Злокачественные опухоли: Практические рекомендации RUSSCO #3s2. 2022;12:607-26 [Nosov DA, Volkova MI, Gladkov OA, et al. Prakticheskiie rekomendatsii po lecheniiu raka predstatel'noi zhelezy. Zlokachestvennyie opukholi: Prakticheskiie rekomendatsii RUSSCO #3s2. 2022;12:607-26 (in Russian)].
Supplementary files
